Sustained release formulations

Details for Australian Patent Application No. 2005237542 (hide)

Owner Amgen Inc.

Inventors Gu, Jian Hua; Goldenberg, Merrill S.

Agent Shelston IP

Pub. Number AU-B-2005237542

PCT Pub. Number WO2005/105057

Priority 60/565,247 23.04.04 US

Filing date 25 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 17 December 2009

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/105057 Priority application(s): WO2005/105057

17 December 2009 Application Accepted

  Published as AU-B-2005237542

15 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237543-Statins for the treatment of ocular hypertension and glaucoma

2005237541-Antifungal drug delivery